These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33272166)

  • 1. Lymphatic Drug Transport and Associated Drug Delivery Technologies: A Comprehensive Review.
    Punjabi MS; Naha A; Shetty D; Nayak UY
    Curr Pharm Des; 2021; 27(17):1992-1998. PubMed ID: 33272166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
    Managuli RS; Raut SY; Reddy MS; Mutalik S
    Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations.
    Franco V; Gershkovich P; Perucca E; Bialer M
    Clin Pharmacokinet; 2020 Dec; 59(12):1493-1500. PubMed ID: 32785853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update.
    Trevaskis NL; Charman WN; Porter CJ
    Adv Drug Deliv Rev; 2008 Mar; 60(6):702-16. PubMed ID: 18155316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties.
    Ryšánek P; Grus T; Šíma M; Slanař O
    Pharm Res; 2020 Aug; 37(9):166. PubMed ID: 32770268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of lymphatic transport in enhancing oral protein and peptide drug delivery.
    Wasan KM
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1047-58. PubMed ID: 12455465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cracking the intestinal lymphatic system window utilizing oral delivery vehicles for precise therapy.
    Miao YB; Xu T; Gong Y; Chen A; Zou L; Jiang T; Shi Y
    J Nanobiotechnology; 2023 Aug; 21(1):263. PubMed ID: 37559085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
    Wu H; Zhou A; Lu C; Wang L
    Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic Drug Absorption via the Enterocytes: Pharmacokinetic Simulation, Modeling, and Considerations for Optimal Drug Development.
    Brocks DR; Davies NM
    J Pharm Pharm Sci; 2018; 21(1s):254s-270s. PubMed ID: 30348249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.
    Cherniakov I; Domb AJ; Hoffman A
    Expert Opin Drug Deliv; 2015 Jul; 12(7):1121-33. PubMed ID: 25556987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-Based Nanocarriers for Lymphatic Transportation.
    Vishwakarma N; Jain A; Sharma R; Mody N; Vyas S; Vyas SP
    AAPS PharmSciTech; 2019 Jan; 20(2):83. PubMed ID: 30673895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.
    Chaudhary S; Garg T; Murthy RS; Rath G; Goyal AK
    J Drug Target; 2014 Dec; 22(10):871-82. PubMed ID: 25148607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides.
    Holm R; Porter CJ; Edwards GA; Müllertz A; Kristensen HG; Charman WN
    Eur J Pharm Sci; 2003 Sep; 20(1):91-7. PubMed ID: 13678797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral Bioavailability.
    Hu L; Quach T; Han S; Lim SF; Yadav P; Senyschyn D; Trevaskis NL; Simpson JS; Porter CJ
    Angew Chem Int Ed Engl; 2016 Oct; 55(44):13700-13705. PubMed ID: 27482655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Lymphatic System: A Sometimes-Forgotten Compartment in Pharmaceutical Sciences.
    Yousef M; Silva D; Bou Chacra N; Davies N; Löbenberg R
    J Pharm Pharm Sci; 2021; 24():533-547. PubMed ID: 34694988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipidic prodrug approach for improved oral drug delivery and therapy.
    Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
    Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal transport as a potential determinant of drug bioavailability.
    Nauli AM; Nauli SM
    Curr Clin Pharmacol; 2013 Aug; 8(3):247-55. PubMed ID: 23343017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of intestinal lymphatic transport on the systemic exposure and brain deposition of a novel highly lipophilic compound with structural similarity to cholesterol.
    Caliph SM; Faassen FW; Porter CJ
    J Pharm Pharmacol; 2014 Oct; 66(10):1377-87. PubMed ID: 24821499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart design approaches for orally administered lipophilic prodrugs to promote lymphatic transport.
    Elz AS; Trevaskis NL; Porter CJH; Bowen JM; Prestidge CA
    J Control Release; 2022 Jan; 341():676-701. PubMed ID: 34896450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes.
    Babalola KT; Arora M; Ganugula R; Agarwal SK; Mohan C; Kumar MNVR
    Pharmacol Rev; 2024 Feb; 76(2):228-250. PubMed ID: 38351070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.